web_sources_5202_07f

web_sources_5202_07f - Web Resources A1. Loss Prevention...

Info iconThis preview shows pages 1–3. Sign up to view the full content.

View Full Document Right Arrow Icon
Web Resources A1. Loss Prevention Loss Prevention Blog A2. Pharmacoeconomics of Inhaled Anesthetic Agents: Considerations for the Pharmacist (Introduction) From American Journal of Health-System Pharmacy Pharmacoeconomics of Inhaled Anesthetic Agents: Considerations for the Pharmacist Posted 11/11/2004 Eric L. Chernin Abstract and Introduction Abstract Purpose: Types of economic analyses used for inhaled anesthetic agents, factors to consider in calculating the cost of inhaled anesthetics, limitations of pharmacoeconomic studies of these agents, and strategies for controlling inhaled anesthetic costs are discussed. Summary: Inhaled anesthetic agents comprise a substantial component of drug budgets. Calculation of the cost of administering an inhaled anesthetic should take into consideration the cost per mL, potency, waste, concentration and duration of gas delivery, fresh gas flow rate, molecular weight, and density. The use of newer inhaled anesthetic agents with low solubility in blood and tissue provides a more rapid recovery from anesthesia than older, more soluble agents, and also provides the same level of control of depth of anesthesia at a lower fresh gas flow rate and possibly a lower cost than older agents at a higher fresh gas flow rate. A more rapid recovery may facilitate fast-track recovery and yield cost savings if it allows the completion of additional surgical cases or allows a reduction in personnel overtime expenses. Interpretation of pharmacoeconomic studies of inhaled anesthetics requires an appreciation of the limitations in methodology and ability to extrapolate results from one setting to another. Pharmacists' efforts to reduce anesthetic waste and collaborate with anesthesiologists to improve the use of these agents can help contain costs, but improving scheduling and efficiency in the operating room has a greater potential to reduce operating room costs. Conclusion: Much can be done to control costs of anesthetic agents without compromising availability of these agents and patient care. Introduction Acquisition costs for all medications have risen dramatically in recent years, outpacing inflation in general, a trend that is likely to continue. Unfortunately, private and governmental reimbursement rates have not kept pace. Hospital administrators tend to focus on readily identifiable causes of increases in drug budgets [1] and require pharmacy departments to justify the purchase of costly new drugs. Medications used in anesthesia may comprise a substantial portion of pharmacy drug budgets in hospitals with large surgery programs. Anesthesia drugs account for 10-13% of the drug budget at Sarasota Memorial Hospital. Unfortunately, drug costs often are viewed by administrators in a compartmentalized manner, according to the budgets of individual departments, rather than from a broader institutional perspective that takes into consideration costs (or savings) associated with drug use, and patient outcomes, beyond those associated with acquisition costs (e.g., costs of nursing staff time, adverse effects, time to
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
discharge). Therefore, pharmacists are in the position of being held responsible administratively for the
Background image of page 2
Image of page 3
This is the end of the preview. Sign up to access the rest of the document.

Page1 / 43

web_sources_5202_07f - Web Resources A1. Loss Prevention...

This preview shows document pages 1 - 3. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online